(2010). Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial.
Chicago Style (17th ed.) CitationFour Year Efficacy of Prophylactic Human Papillomavirus Quadrivalent Vaccine Against Low Grade Cervical, Vulvar, and Vaginal Intraepithelial Neoplasia and Anogenital Warts: Randomised Controlled Trial. 2010.
MLA (8th ed.) CitationFour Year Efficacy of Prophylactic Human Papillomavirus Quadrivalent Vaccine Against Low Grade Cervical, Vulvar, and Vaginal Intraepithelial Neoplasia and Anogenital Warts: Randomised Controlled Trial. 2010.
Warning: These citations may not always be 100% accurate.